Literature DB >> 25342737

Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine.

Kiyotake Ishikawa1, Kenneth Fish2, Jaume Aguero2, Elisa Yaniz-Galende2, Dongtak Jeong2, Changwon Kho2, Lisa Tilemann2, Lauren Fish2, Lifan Liang2, Ahmed A Eltoukhy2, Daniel G Anderson2, Krisztina Zsebo2, Kevin D Costa2, Roger J Hajjar2.   

Abstract

BACKGROUND: Stem cell factor (SCF), a ligand of the c-kit receptor, is a critical cytokine, which contributes to cell migration, proliferation, and survival. It has been shown that SCF expression increases after myocardial infarction (MI) and may be involved in cardiac repair. The aim of this study was to determine whether gene transfer of membrane-bound human SCF improves cardiac function in a large animal model of MI. METHODS AND
RESULTS: A transmural MI was created by implanting an embolic coil in the left anterior descending artery in Yorkshire pigs. One week after the MI, the pigs received direct intramyocardial injections of either a recombinant adenovirus encoding for SCF (Ad.SCF, n=9) or β-gal (Ad.β-gal, n=6) into the infarct border area. At 3 months post-MI, ejection fraction increased by 12% relative to baseline after Ad.SCF therapy, whereas it decreased by 4.2% (P=0.004) in pigs treated with Ad.β-gal. Preload-recruitable stroke work was significantly higher in pigs after SCF treatment (Ad.SCF, 55.5±11.6 mm Hg versus Ad.β-gal, 31.6±12.6 mm Hg, P=0.005), indicating enhanced cardiac function. Histological analyses confirmed the recruitment of c-kit(+) cells as well as a reduced degree of apoptosis 1 week after Ad.SCF injection. In addition, increased capillary density compared with pigs treated with Ad.β-gal was found at 3 months and suggests an angiogenic role of SCF.
CONCLUSIONS: Local overexpression of SCF post-MI induces the recruitment of c-kit(+) cells at the infarct border area acutely. In the chronic stages, SCF gene transfer was associated with improved cardiac function in a preclinical model of ischemic cardiomyopathy.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  angiogenesis; gene therapy; myocardial infarction; paracrine factor

Mesh:

Substances:

Year:  2014        PMID: 25342737      PMCID: PMC4303518          DOI: 10.1161/CIRCHEARTFAILURE.114.001711

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  31 in total

1.  Gene transfer for ischemic heart failure in a preclinical model.

Authors:  Kiyotake Ishikawa; Dennis Ladage; Lisa Tilemann; Kenneth Fish; Yoshiaki Kawase; Roger J Hajjar
Journal:  J Vis Exp       Date:  2011-05-15       Impact factor: 1.355

2.  Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant?

Authors:  Kiyotake Ishikawa; Elie R Chemaly; Lisa Tilemann; Kenneth Fish; Dennis Ladage; Jaime Aguero; Torsten Vahl; Carlos Santos-Gallego; Yoshiaki Kawase; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 3.  Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.

Authors:  Tycho I G van der Spoel; Sanne J Jansen of Lorkeers; Pierfrancesco Agostoni; Eric van Belle; Mariann Gyöngyösi; Joost P G Sluijter; Maarten J Cramer; Pieter A Doevendans; Steven A J Chamuleau
Journal:  Cardiovasc Res       Date:  2011-04-14       Impact factor: 10.787

4.  Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells.

Authors:  Elisa Yaniz-Galende; Jiqiu Chen; Elie Chemaly; Lifan Liang; Jean-Sebastien Hulot; LaTronya McCollum; Teresa Arias; Valentin Fuster; Krisztina M Zsebo; Roger J Hajjar
Journal:  Circ Res       Date:  2012-08-29       Impact factor: 17.367

5.  Neonatal transfer of membrane-bound stem cell factor improves survival and heart function in aged mice after myocardial ischemia.

Authors:  Zhuo Sun; Chyan-Jang Lee; Salvador Mejia-Guerrero; Yuemei Zhang; Koji Higuchi; Ren-Ke Li; Jeffrey A Medin
Journal:  Hum Gene Ther       Date:  2012-11-23       Impact factor: 5.695

6.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Authors:  Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa
Journal:  Lancet       Date:  2011-11-14       Impact factor: 79.321

Review 7.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

8.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

9.  Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.

Authors:  Atul R Chugh; Garth M Beache; John H Loughran; Nathan Mewton; Julius B Elmore; Jan Kajstura; Patroklos Pappas; Antone Tatooles; Marcus F Stoddard; Joao A C Lima; Mark S Slaughter; Piero Anversa; Roberto Bolli
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

10.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.

Authors:  Raj R Makkar; Rachel R Smith; Ke Cheng; Konstantinos Malliaras; Louise Ej Thomson; Daniel Berman; Lawrence Sc Czer; Linda Marbán; Adam Mendizabal; Peter V Johnston; Stuart D Russell; Karl H Schuleri; Albert C Lardo; Gary Gerstenblith; Eduardo Marbán
Journal:  Lancet       Date:  2012-02-14       Impact factor: 79.321

View more
  18 in total

1.  Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.

Authors:  Irene C Turnbull; Ahmed A Eltoukhy; Kenneth M Fish; Mathieu Nonnenmacher; Kiyotake Ishikawa; Jiqiu Chen; Roger J Hajjar; Daniel G Anderson; Kevin D Costa
Journal:  Mol Ther       Date:  2015-10-16       Impact factor: 11.454

2.  Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?

Authors:  Kenneth M Fish; Kiyotake Ishikawa; Roger J Hajjar
Journal:  Coron Artery Dis       Date:  2018-03       Impact factor: 1.439

3.  Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.

Authors:  Konstantinos E Hatzistergos; Dieter Saur; Barbara Seidler; Wayne Balkan; Matthew Breton; Krystalenia Valasaki; Lauro M Takeuchi; Ana Marie Landin; Aisha Khan; Joshua M Hare
Journal:  Circ Res       Date:  2016-08-01       Impact factor: 17.367

Review 4.  Targeted delivery of therapeutic agents to the heart.

Authors:  Susmita Sahoo; Taro Kariya; Kiyotake Ishikawa
Journal:  Nat Rev Cardiol       Date:  2021-01-26       Impact factor: 32.419

Review 5.  c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Authors:  Patrizia Nigro; Gianluca Lorenzo Perrucci; Aoife Gowran; Marco Zanobini; Maurizio C Capogrossi; Giulio Pompilio
Journal:  Cell Mol Life Sci       Date:  2015-01-10       Impact factor: 9.261

Review 6.  Human Cardiac Gene Therapy.

Authors:  Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

7.  Mesenchymal Stem Cells Drive Cardiac Stem Cell Chemotaxis, Proliferation, and Phenotype via CXCR4 and cKit Signaling.

Authors:  Kenneth Michael Fish
Journal:  Circ Res       Date:  2016-09-30       Impact factor: 17.367

8.  Cardiac c-Kit Biology Revealed by Inducible Transgenesis.

Authors:  Natalie A Gude; Fareheh Firouzi; Kathleen M Broughton; Kelli Ilves; Kristine P Nguyen; Christina R Payne; Veronica Sacchi; Megan M Monsanto; Alexandria R Casillas; Farid G Khalafalla; Bingyan J Wang; David E Ebeid; Roberto Alvarez; Walter P Dembitsky; Barbara A Bailey; Jop van Berlo; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-10       Impact factor: 17.367

Review 9.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

Review 10.  Stimulating endogenous cardiac repair.

Authors:  Amanda Finan; Sylvain Richard
Journal:  Front Cell Dev Biol       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.